<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-antibiotics-10-00092">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qiao</surname>
    <given-names>J.X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Hiebert</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Schumacher</surname>
    <given-names>W.A.</given-names>
   </name>
   <name>
    <surname>Spronk</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>C.G.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hua</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Price</surname>
    <given-names>L.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: Low clearance and small volume of distribution</article-title>
  <source>ChemMedChem</source>
  <year>2014</year>
  <volume>9</volume>
  <fpage>2327</fpage>
  <lpage>2343</lpage>
  <pub-id pub-id-type="doi">10.1002/cmdc.201402141</pub-id>
  <?supplied-pmid 24989964?>
  <pub-id pub-id-type="pmid">24989964</pub-id>
 </element-citation>
</ref>
